First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 3.94 CAD -4.83% Market Closed
Updated: May 21, 2024

HLS Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
M
MNX

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Operating Expenses
-$71.1m
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
-31%
M
Manitex Capital Inc
XTSX:MNX
Operating Expenses
-CA$965.4k
CAGR 3-Years
-41%
CAGR 5-Years
32%
CAGR 10-Years
15%

See Also

What is HLS Therapeutics Inc's Operating Expenses?
Operating Expenses
-71.1m USD

Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Operating Expenses amounts to -71.1m USD.

What is HLS Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-31%

Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for HLS Therapeutics Inc have been -3% over the past three years , -6% over the past five years , and -31% over the past ten years .